<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-09T09:21:46+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-NGA-T-NTBLCP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis - Nigeria (01-Jan-2019-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Nigeria, Tuberculosis, National Tuberculosis &amp; Leprosy Control Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To ensure universal access to high-quality, patient-centred, prevention, diagnosis and treatment services for TB, TB/HIV and DR-TB by 2020; Responsive and resilient health systems that promote universal access to quality health care services by 2020. Objectives: To increase case notification rate of all forms of TB from 55.1/100,000 population in 2017 to 287 per 100,000 population in 2020; To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients; To enrol 100% of diagnosed DR-TB patients on appropriate treatment by 2020; Strengthen health systems for delivery of packages of essential health care services.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="15" role="2" crs-channel-code="12004">
      <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
    </participating-org>
    <participating-org type="15" role="4" crs-channel-code="12004">
      <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
    </participating-org>
    <other-identifier ref="NGA-T-NTBLCPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-01-01" />
    <activity-date type="2" iso-date="2019-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="NG" percentage="100">
      <narrative>Nigeria</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="81.13">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="18.87">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="4af90c22-07f1-45ad-b696-8b97763feda6" percentage="0.2">
        <description>
          <narrative>Multicomponent -&gt; Payment for results -&gt; Payment for results</narrative>
        </description>
      </budget-item>
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="3.93">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="3.96">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="7.09">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="2.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="0.97">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="f9be36a8-948e-4f4f-860d-8e162eeaa510" percentage="0.54">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="a4cf383e-48f0-4449-bdfd-4fefcc86f8e3" percentage="1.8">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="5def6266-3379-441d-b565-1d99bde3edd1" percentage="1.56">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="19.13">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="14.88">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="0.69">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="4.47">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="4.69">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="0da342b5-b462-4465-bf9a-1fdb9d39596f" percentage="0.4">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Removing human rights and gender related barriers to TB care and prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="33.48">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">13132453.12</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">26197795.06</value>
    </budget>
    <capital-spend percentage="3.83" />
    <transaction ref="fdec4f4d-d9ad-4c02-88c9-7e07aa9e1396">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-02-14" />
      <value currency="USD" value-date="2019-02-14">30235171.55</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1fd00c58-1e5c-4687-bae8-d97aae697c10">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-19" />
      <value currency="USD" value-date="2019-02-19">2592649.43</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="12706ca9-5347-410c-a905-6e6243cf0f4f">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-26" />
      <value currency="USD" value-date="2019-03-26">1180335.47</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="09b8350e-1495-44f2-bbf3-5be186aed53b">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-10" />
      <value currency="USD" value-date="2019-05-10">113804.27</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d4850237-893a-4731-9f77-fc862bd5bacc">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-20" />
      <value currency="USD" value-date="2019-05-20">50000.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ce45d624-bafd-4bcc-8d03-b39b7dc0aa54">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-04" />
      <value currency="USD" value-date="2019-06-04">797899.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="441454ea-2559-4abb-882a-c2003e8c1748">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-25" />
      <value currency="USD" value-date="2019-06-25">846864.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a9ec01fe-9758-4733-aca8-c94c288632c2">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-25" />
      <value currency="USD" value-date="2019-06-25">6863862.75</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d7d6add3-8406-4862-b991-350cb89bd8d7">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-09-24" />
      <value currency="USD" value-date="2019-09-24">257139.54</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b372dd65-fcba-422f-9bd9-11c85467442b">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-11-14" />
      <value currency="USD" value-date="2019-11-14">8979.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="23815c12-d98d-423b-afed-f1a39db231aa">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-06" />
      <value currency="USD" value-date="2019-12-06">16.53</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8727c119-5304-4283-b075-008e3ef8ed6b">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-19" />
      <value currency="USD" value-date="2019-12-19">1330172.64</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4fcd5b06-0acf-4c0e-9c7a-de121b462814">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-19" />
      <value currency="USD" value-date="2019-12-19">225405.20</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a91ca675-14fe-4c99-aebe-67adffca209e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-14" />
      <value currency="USD" value-date="2020-01-14">71367.41</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4fea2181-f9d5-4b21-b042-cc163000ef7d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-30" />
      <value currency="USD" value-date="2020-01-30">1102.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3b9453d0-8e0e-4004-a3f2-92589eede0c7">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-13" />
      <value currency="USD" value-date="2020-02-13">3964427.73</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7e45045a-b5b7-45c9-8153-37cbd26c8db2">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-18" />
      <value currency="USD" value-date="2020-02-18">15346.86</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="88924c84-a971-4b11-858a-d1a472148c4e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-18" />
      <value currency="USD" value-date="2020-02-18">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="948845b6-d2f5-405f-8914-3adcf6fb6cc5">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-27" />
      <value currency="USD" value-date="2020-02-27">20951.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2b8daf6e-af10-453e-9704-08cfb2311570">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-27" />
      <value currency="USD" value-date="2020-02-27">31402.61</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f8a42154-1169-4264-bdcd-1cdd764e114e">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-15" />
      <value currency="USD" value-date="2020-05-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d47d39fe-f84c-4713-8eb1-c364446e3ea9">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-05-19" />
      <value currency="USD" value-date="2020-05-19">221.14</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0dd7affc-1eed-4380-85b5-69320c4bde0e">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-27" />
      <value currency="USD" value-date="2020-05-27">-16166.34</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2ba523db-3492-4bc8-92a1-75a9e75e8d7b">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-27" />
      <value currency="USD" value-date="2020-05-27">312680.51</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c2ac7a20-f28a-4bef-a233-7f440b79e2e1">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-17" />
      <value currency="USD" value-date="2020-06-17">-312680.51</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cd1e0adb-9b7c-401c-b5b8-31fdaba5964d">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-17" />
      <value currency="USD" value-date="2020-06-17">958447.25</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f883e10a-197e-48a1-b734-52ba56bdd184">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-24" />
      <value currency="USD" value-date="2020-06-24">4790839.36</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4df715b-b8e8-43a0-bea9-7b26219edd5c">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-24" />
      <value currency="USD" value-date="2020-06-24">65852.48</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c3602e84-94f5-4b4b-b390-1020813fc952">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-08" />
      <value currency="USD" value-date="2020-07-08">-958447.25</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="46536d2a-5c89-471e-8e10-f1af29ae53a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-08" />
      <value currency="USD" value-date="2020-07-08">972059.39</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d29b5213-b53b-499b-a0ef-1ac0a9bd7ce4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-14" />
      <value currency="USD" value-date="2020-07-14">3877.94</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4c0457fb-55c5-491d-a71e-f2ef5ef36c26">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-24" />
      <value currency="USD" value-date="2020-07-24">-7554645.87</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9f011875-40df-444e-8ad5-0d53264d4b77">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-24" />
      <value currency="USD" value-date="2020-07-24">9687815.63</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f7902992-5fa6-40a2-a690-7de68809084a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-29" />
      <value currency="USD" value-date="2020-07-29">797899.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9203d37d-e6ed-4f24-8e65-624c8be936db">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-19" />
      <value currency="USD" value-date="2020-08-19">14331.10</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1ef5c89e-0a7f-4f25-8ad2-1a3f53454d54">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-19" />
      <value currency="USD" value-date="2020-08-19">2861721.63</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fbdf834e-11bc-40b2-968f-763f4a80240d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-24" />
      <value currency="USD" value-date="2020-08-24">571013.92</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="31355771-db4d-43a2-a4ed-90b6c9090eed">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-01" />
      <value currency="USD" value-date="2020-10-01">272918.11</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="15f9964a-03f8-499b-be2f-1862443c6733">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-04" />
      <value currency="USD" value-date="2020-11-04">3357606.25</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="332b806f-6889-484b-acc0-05f8af75530e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-06" />
      <value currency="USD" value-date="2020-11-06">57537.92</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5a8d040b-9a43-4dff-b384-b08a907d8aad">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-19" />
      <value currency="USD" value-date="2020-11-19">6141.90</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6166e706-bfac-4e0b-b073-bd78d3f7977f">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-26" />
      <value currency="USD" value-date="2020-11-26">11.42</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a324de3b-d09c-4a47-9af4-c60f864c4065">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2c44de13-37bc-4258-a446-a9e02c40afaf">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">536118.37</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7ee2966a-8236-4056-b2b2-3a387ae109e4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-10" />
      <value currency="USD" value-date="2020-12-10">24788.20</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f17b408b-e0ea-4229-beec-229a81583469">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-06" />
      <value currency="USD" value-date="2021-01-06">529948.38</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6198906c-5513-4ded-a598-f3eeca8e56b7">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-11" />
      <value currency="USD" value-date="2021-01-11">529948.38</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4995d219-818d-4062-9a38-29011d6e93cf">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-10" />
      <value currency="USD" value-date="2021-02-10">-41911.88</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="60619edf-b05a-4478-9891-101e97035b74">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-10" />
      <value currency="USD" value-date="2021-02-10">29491.88</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="66498158-6f75-4adb-8ce7-369e6e6741b1">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-16" />
      <value currency="USD" value-date="2021-02-16">12276.98</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="05f0c849-7361-420e-abf3-28414fbd39b4">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-16" />
      <value currency="USD" value-date="2021-02-16">-29491.88</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f10d7577-81e4-4eb5-a8c7-544b1cdcacc4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-19" />
      <value currency="USD" value-date="2021-02-19">868058.89</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aaf644c7-f80a-4ab9-84b1-28ab95c0544b">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-24" />
      <value currency="USD" value-date="2021-02-24">-12276.98</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a5eb4349-aae0-4fc7-bb53-4bfcafee51eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-05" />
      <value currency="USD" value-date="2021-03-05">4879.50</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6237a6d0-5b92-45a4-a191-bfe45ab611dc">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-24" />
      <value currency="USD" value-date="2021-06-24">275138.97</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d34fb0b0-96c7-4f00-9a4f-cff263f7ac65">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-08-08" />
      <value currency="USD" value-date="2021-08-08">104634.66</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0303bdc0-9d90-4ec9-8536-424050006439">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-08-08" />
      <value currency="USD" value-date="2021-08-08">-104634.66</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4cae1359-7bf4-44c5-a106-9ba6fc7e6c14">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-09-19" />
      <value currency="USD" value-date="2021-09-19">104634.66</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d0b07392-bd32-4cdf-9c6e-30ee1886836c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-15" />
      <value currency="USD" value-date="2021-10-15">0.28</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0c00b0d6-fd87-4cc0-a140-67e695f7ea35">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-15" />
      <value currency="USD" value-date="2021-10-15">-104634.66</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b3635cbb-82d7-429b-bf12-a59c09c1cec1">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-14" />
      <value currency="USD" value-date="2021-12-14">15676.72</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6b39ef3f-e4d1-40ee-a538-869850c1a576">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-14" />
      <value currency="USD" value-date="2021-12-14">-0.28</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aed15bbd-a750-45ff-8758-49423c708e7a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-16" />
      <value currency="USD" value-date="2021-12-16">-15676.72</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e2438cf0-eae6-4ad5-9c41-b61ec4019324">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-13" />
      <value currency="USD" value-date="2022-05-13">-965920.02</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP01-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">13132453.14</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP01, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP01-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">20125440.00</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP01, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP01-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">109787.00</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP01, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/NGA-T-NTBLCP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 2286.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2216.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 70.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 813.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1473.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3872.12.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1197; Denominator: 3872; Percentage: 30.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7744.25.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2384; Denominator: 7744; Percentage: 30.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4185.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 983.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8370.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2002.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1888; Denominator: 2002; Percentage: 94.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 114; Denominator: 2002; Percentage: 5.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 667; Denominator: 2002; Percentage: 33.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1335; Denominator: 2002; Percentage: 66.7%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 1786.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1756.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 30.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 630.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1156.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 22.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 348.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3678.52.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 997; Denominator: 3679; Percentage: 27.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7357.04.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1975; Denominator: 7357; Percentage: 26.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4185.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 738.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8370.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1493.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1469; Denominator: 1493; Percentage: 98.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 24; Denominator: 1493; Percentage: 1.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 488; Denominator: 1493; Percentage: 32.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1005; Denominator: 1493; Percentage: 67.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 448; Denominator: 1493; Percentage: 30%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1045; Denominator: 1493; Percentage: 70%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="87.5">
          <comment>
            <narrative>Numerator: 7; Denominator: 8.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100" />
          <actual value="100" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100" />
          <actual value="90" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100" />
          <actual value="92.2">
            <comment>
              <narrative>Numerator: 364; Denominator: 395.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100" />
          <actual value="80">
            <comment>
              <narrative>Numerator: 80; Denominator: 100.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="38.14">
          <comment>
            <narrative>Numerator: 40009; Denominator: 104904.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="70" />
          <actual value="60" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="70" />
          <actual value="58" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="75" />
          <actual value="52.9">
            <comment>
              <narrative>Numerator: 31966; Denominator: 60473.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="75" />
          <actual value="54.2">
            <comment>
              <narrative>Numerator: 75103; Denominator: 138573.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="76.08">
          <comment>
            <narrative>Numerator: 26054; Denominator: 34247.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="80" />
          <actual value="78" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="80" />
          <actual value="78" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90" />
          <actual value="79.2">
            <comment>
              <narrative>Numerator: 30123; Denominator: 38032.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="95" />
          <actual value="79.1">
            <comment>
              <narrative>Numerator: 11959; Denominator: 15118.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 10258; Denominator: 11734; Percentage: 87.42%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 15958; Denominator: 17731; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4858; Denominator: 17731; Percentage: 27.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 31916; Denominator: 35462; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9772; Denominator: 35462; Percentage: 27.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 17630; Denominator: 19163; Percentage: 92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4264; Denominator: 19163; Percentage: 22.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 35260; Denominator: 38326; Percentage: 92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8825.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 21667; Denominator: 104904; Percentage: 20.65%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 20341.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8765; Denominator: 20341; Percentage: 43.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40682.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26226; Denominator: 40682; Percentage: 64.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 24071.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17443.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 48143.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 42404.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 11862; Denominator: 104904; Percentage: 11.31%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 39684.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7544; Denominator: 39684; Percentage: 19%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 79367.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17250; Denominator: 79367; Percentage: 21.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 50037.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12279.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 100073.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 35855.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 104904.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 97454.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 7450.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 77647.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 40018.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 64886.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 86869.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 3953.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 14082.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 118324.37.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 56649; Denominator: 118324; Percentage: 47.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 236648.75.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 120266; Denominator: 236648; Percentage: 50.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 127881.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 60473.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 255762.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 138573.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 130132; Denominator: 138573; Percentage: 93.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 8441; Denominator: 138573; Percentage: 6.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 102741; Denominator: 138573; Percentage: 74.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 54307; Denominator: 138573; Percentage: 39.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 84266; Denominator: 138573; Percentage: 60.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 121114; Denominator: 135638; Percentage: 89.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 7358; Denominator: 135638; Percentage: 5.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 10101; Denominator: 135638; Percentage: 7.4%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 104904.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 71713.84.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 56649; Denominator: 71714; Percentage: 79%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 143427.69.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 120266; Denominator: 143428; Percentage: 83.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 83872.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 60473.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 167745.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 138573.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="79" />
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90" />
          <actual value="89.1" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90" />
          <actual value="68.4">
            <comment>
              <narrative>Numerator: 61.6; Denominator: 90.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="92" />
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="96" />
          <actual value="97" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="96" />
          <actual value="94.4" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="98" />
          <actual value="94.5">
            <comment>
              <narrative>Numerator: 8040; Denominator: 8509.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="98" />
          <actual value="103.3">
            <comment>
              <narrative>Numerator: 95; Denominator: 92.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="86" />
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90" />
          <actual value="87" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90" />
          <actual value="87.7">
            <comment>
              <narrative>Numerator: 105532; Denominator: 120266.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="84.5">
          <comment>
            <narrative>Numerator: 11899; Denominator: 14082.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100" />
          <actual value="96" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100" />
          <actual value="91.4">
            <comment>
              <narrative>Numerator: 11017; Denominator: 12052.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100" />
          <actual value="90.4">
            <comment>
              <narrative>Numerator: 4457; Denominator: 4931.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100" />
          <actual value="91.1">
            <comment>
              <narrative>Numerator: 8849; Denominator: 9709.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="45.55">
          <comment>
            <narrative>Numerator: 91873; Denominator: 201707.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="74.42">
            <comment>
              <narrative>Numerator: 71109.5; Denominator: 95558.</narrative>
            </comment>
          </target>
          <actual value="61.7">
            <comment>
              <narrative>Numerator: 111402; Denominator: 180490.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="74.42">
            <comment>
              <narrative>Numerator: 142219; Denominator: 191116.</narrative>
            </comment>
          </target>
          <actual value="94.2">
            <comment>
              <narrative>Numerator: 162299; Denominator: 172391.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="89.27">
            <comment>
              <narrative>Numerator: 80186; Denominator: 89825.</narrative>
            </comment>
          </target>
          <actual value="50.9">
            <comment>
              <narrative>Numerator: 77084; Denominator: 151406.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="89.27">
            <comment>
              <narrative>Numerator: 160372; Denominator: 179650.</narrative>
            </comment>
          </target>
          <actual value="55.2">
            <comment>
              <narrative>Numerator: 216721; Denominator: 392481.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="96.23">
          <comment>
            <narrative>Numerator: 100951; Denominator: 104904.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100" />
          <actual value="97" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100" />
          <actual value="97.3">
            <comment>
              <narrative>Numerator: 113954; Denominator: 117149.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100" />
          <actual value="94.7">
            <comment>
              <narrative>Numerator: 55882; Denominator: 59023.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100" />
          <actual value="95">
            <comment>
              <narrative>Numerator: 95; Denominator: 100.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-NGA-T-NTBLCP-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis - Nigeria (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Nigeria, Tuberculosis, National Tuberculosis &amp; Leprosy Control Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To accelerate efforts at ending TB epidemic in Nigeria by ensuring access to comprehensive and high quality patients' centered and community owned TB (TB. TB/HIV and DR-TB) services for all Nigerians by 2025. Objectives: Improve health product management specifically contributing to warehouse upgrade; Scale-up TB services through supply of essential equipment &amp; consumables; To enrol 100% of diagnosed DR-TB patients on appropriate treatment by 2023.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="15" role="2" crs-channel-code="12004">
      <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
    </participating-org>
    <participating-org type="15" role="4" crs-channel-code="12004">
      <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
    </participating-org>
    <other-identifier ref="NGA-T-NTBLCPP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="NG" percentage="100">
      <narrative>Nigeria</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="72.71">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="27.29">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="3.48">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="6.15">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="3.8">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="1.97">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="5.34">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="cc2a3288-298b-4e87-9cd4-3b8c1601d54c" percentage="0.81">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="45f58950-e70b-425c-a83d-28115a57a936" percentage="0.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="73afa0ce-d818-4bb2-adeb-c13f28c03a1f" percentage="5.57">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="951569a8-a591-40fc-9492-c7eb2322279f" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="0.06">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="22851d66-f7e4-4cc5-950a-ad9cac3568a2" percentage="0.93">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="13.26">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="0.6">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="20.98">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="2.37">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="0.77">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="33.74">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">18742363.75</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">36882120.99</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">98256101.69</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">40441158.95</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">4239167.90</value>
    </budget>
    <capital-spend percentage="40.3" />
    <transaction ref="ed55f627-3483-4f18-b982-b089944ce397">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-14" />
      <value currency="USD" value-date="2020-12-14">36104125.75</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0505f0e9-a036-45a2-9816-cc89f7b8b657">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-26" />
      <value currency="USD" value-date="2021-01-26">-36104125.75</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="484c9ad0-f8d5-4d11-a762-63537f01c093">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-26" />
      <value currency="USD" value-date="2021-01-26">36104125.75</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="08c9aa96-2ef2-4431-bbf4-cb68a04c12de">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-05" />
      <value currency="USD" value-date="2021-02-05">4001908.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dfd7891e-a69b-4b7b-b8e9-b1d82169b1fe">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-30" />
      <value currency="USD" value-date="2021-04-30">166664.77</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="afe3db87-9439-4f0d-804d-43d8f0009441">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-05-21" />
      <value currency="USD" value-date="2021-05-21">869696.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0582f887-f84f-4eec-bbee-b55a241a1e49">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-01" />
      <value currency="USD" value-date="2021-07-01">154166.49</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ef2ec9ab-311f-4b9c-b9aa-2e213607c085">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-01" />
      <value currency="USD" value-date="2021-07-01">697447.28</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cdc46010-2c48-45c9-9be1-47c4de756eff">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">4951948.98</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="31355e8f-ae5a-4534-9892-2e0ee4e80df0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bc40b33e-0b44-4e04-93dd-d469dc7439fa">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-22" />
      <value currency="USD" value-date="2021-07-22">1020333.18</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eb673909-4858-4a24-8faf-3992888e0091">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-23" />
      <value currency="USD" value-date="2021-07-23">11385.50</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8212184c-6871-4741-9a4f-42ac55b53c51">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-27" />
      <value currency="USD" value-date="2021-07-27">242425.30</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1d16ced2-6168-499a-8bb4-7badfc9f2331">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-08" />
      <value currency="USD" value-date="2021-09-08">7332601.67</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bfdfd49b-003b-4e8c-87cc-3a07879f4913">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-20" />
      <value currency="USD" value-date="2021-09-20">201541.33</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="eaf935d8-645e-4866-93b4-30f9131d5bb7">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">8640188.73</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="550a3e41-b8fe-4922-84c3-0dd6601ea5de">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">621285.59</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6d1df52e-fa72-4fd2-9f30-305102cecfec">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-21" />
      <value currency="USD" value-date="2021-10-21">28628.69</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9973485e-5ffc-432d-88e8-2dc6bd59dcc1">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">228828.70</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7ee5518d-8c18-47d8-afc1-ee5014a3d8fe">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-15" />
      <value currency="USD" value-date="2021-12-15">-12255.28</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba95c7db-6230-433c-a309-1453ff7cf8ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">288578.05</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="912cf91e-5a96-4538-a2cc-197137c44435">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-27" />
      <value currency="USD" value-date="2022-01-27">669656.03</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1215967f-fd3c-4298-a6a1-b28902b9fda0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-27" />
      <value currency="USD" value-date="2022-01-27">10190.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a75a69da-ec4e-47c9-b8ec-62883e926bd9">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8f335c2c-5447-46e6-9133-98cf3e6f8299">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">100000.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a64900bd-ab27-4d57-b6d3-aabadf634598">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-14" />
      <value currency="USD" value-date="2022-03-14">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="325fbba3-3b5e-442f-b53e-e914cfded744">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-17" />
      <value currency="USD" value-date="2022-03-17">2481540.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f000d595-dd52-4954-8e4f-d9e1fad550c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-17" />
      <value currency="USD" value-date="2022-03-17">869696.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8896792a-cf5f-4d4c-aba5-7a601f10693a">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-25" />
      <value currency="USD" value-date="2022-03-25">319768.18</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2405976f-cd8f-43d6-a984-ec7b8bc2503a">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-01" />
      <value currency="USD" value-date="2022-04-01">329671.74</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dd43ba2c-b4ef-49bc-b511-2adbf17481f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-18" />
      <value currency="USD" value-date="2022-05-18">279961.59</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e4657c27-5c1a-4402-b897-18c4a02a23b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-10" />
      <value currency="USD" value-date="2022-06-10">-2758338.58</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5c7c35cf-1769-4671-9fd8-55fb58457228">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-10" />
      <value currency="USD" value-date="2022-06-10">20740747.50</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c5b97c6e-2553-47b3-bbe8-9d8d72a4737d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-16" />
      <value currency="USD" value-date="2022-06-16">3869781.44</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2d186360-e7e5-4336-9ebb-8a647bbcd6e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-16" />
      <value currency="USD" value-date="2022-06-16">10608143.06</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9d5672a5-9ab4-4ef8-9030-f5bb4f198edb">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-14" />
      <value currency="USD" value-date="2022-07-14">24714.35</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="40443fc1-09dc-4610-bdfa-18ed1c5aa48d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-21" />
      <value currency="USD" value-date="2022-07-21">2229.09</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="06de58da-9f5e-4569-9ad8-d26b8d626b1a">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-04" />
      <value currency="USD" value-date="2022-08-04">757270.74</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b4f89f50-9bb4-4f8d-9ecb-982ffb60e4d2">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-04" />
      <value currency="USD" value-date="2022-08-04">188851.74</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a5c0542a-f058-48cf-83b5-b000114d2dad">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-04" />
      <value currency="USD" value-date="2022-08-04">10725.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ca23b887-b869-4201-9bbf-68445c8b7ac0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-08-09" />
      <value currency="USD" value-date="2022-08-09">-12863.15</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b7a261ec-4a0e-4910-bc01-a2b75d33af38">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-11" />
      <value currency="USD" value-date="2022-08-11">338079.29</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9e144924-5e17-49df-ba11-8126faca5a82">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-11" />
      <value currency="USD" value-date="2022-08-11">593571.20</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f146135a-1b84-490b-a49a-545bc4397e1e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-25" />
      <value currency="USD" value-date="2022-08-25">2348415.87</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0fd8b892-94b1-4e25-88b5-5ffde4ad68b6">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-25" />
      <value currency="USD" value-date="2022-08-25">1398.14</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f8f752b8-10c5-4ba4-938f-4540f8ccbdf0">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">1693.22</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="016de747-3d3c-4f40-8044-99a6837961d6">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">38510.42</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c83d4021-52ce-49cc-901e-4549b169c934">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-15" />
      <value currency="USD" value-date="2022-10-15">-2024511.02</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1d9231a9-c3cd-4ab4-9ccb-810916e02a35">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-15" />
      <value currency="USD" value-date="2022-10-15">31261773.83</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="61341d92-ae13-40fd-8c38-3de4ee086caf">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-1693.22</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="85e5b67b-9ae7-45c6-a704-41fc6c935124">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-38510.42</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="119d33d6-21af-4377-ac13-e53b9a1ebc26">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-10-20" />
      <value currency="USD" value-date="2022-10-20">10725.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="547999d1-70bd-4ac9-a6ff-36cd6ff39c19">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-02" />
      <value currency="USD" value-date="2022-11-02">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2f09d973-e001-46a5-8925-de81421f1fe0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-22" />
      <value currency="USD" value-date="2022-11-22">1279567.44</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6aa2abac-b2ae-4345-8c73-1d2ffbb309d6">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-22" />
      <value currency="USD" value-date="2022-11-22">16610925.69</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="22b5ab55-367f-48cf-91b7-60cdcb56b4fc">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">19844.33</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="77cd764f-3ea4-4550-9953-c16c5978250a">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-12-08" />
      <value currency="USD" value-date="2022-12-08">2185.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="49588faa-4168-47c7-be77-7b51de2454f3">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-13" />
      <value currency="USD" value-date="2022-12-13">77666.30</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="06f1ead2-3ad0-4f35-b9d1-2b62134c571f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-15" />
      <value currency="USD" value-date="2022-12-15">-19844.33</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dafdfbde-1db0-4bc5-b4a5-cfafd675c336">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-19" />
      <value currency="USD" value-date="2022-12-19">4691335.19</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="20828cff-eaf5-4e23-a861-2d57f08d9a9e">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-21" />
      <value currency="USD" value-date="2022-12-21">-2185.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5c27aabf-35d9-4264-aeea-483165abcc1a">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-22" />
      <value currency="USD" value-date="2022-12-22">1081959.21</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fbe2539e-9e4f-4b0c-95e3-bf4cc43c5aea">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-01-25" />
      <value currency="USD" value-date="2023-01-25">1515626.34</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="75c13617-cf39-4f6a-a375-dd111bc4d993">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-01-25" />
      <value currency="USD" value-date="2023-01-25">-1081959.21</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7ce0c600-0267-4a73-862a-62d5029c2caa">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-01" />
      <value currency="USD" value-date="2023-02-01">250811.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="83373095-40a3-4431-b2b3-36e1ab62e79a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-01" />
      <value currency="USD" value-date="2023-02-01">6533114.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5213aede-8caa-4dad-9e38-1eae96dc4a54">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-27" />
      <value currency="USD" value-date="2023-02-27">-1807629.21</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="45d03279-58b4-4e8d-9822-0eafb151f378">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-27" />
      <value currency="USD" value-date="2023-02-27">17296461.69</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3f4bacf-9f6a-4cd0-92c9-63af003b5737">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-02" />
      <value currency="USD" value-date="2023-03-02">3954300.80</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8f52324-f3c2-4e6f-ab96-d865ff79e5a4">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-02" />
      <value currency="USD" value-date="2023-03-02">227666.30</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c281ff4b-0b6a-400d-8148-f0556b83848d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-02" />
      <value currency="USD" value-date="2023-03-02">1941904.37</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="54e3c4f3-94f1-4759-a0d2-1756a4b5f751">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-14" />
      <value currency="USD" value-date="2023-03-14">209685.77</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="16d84e04-631d-41a4-ab4d-de18fabfd025">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">959023.36</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd526c85-daf6-47ba-a080-2485947ed0b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-13" />
      <value currency="USD" value-date="2023-04-13">876430.96</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5b8ecaa0-cb00-422b-98be-240ddc9eba0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-25" />
      <value currency="USD" value-date="2023-04-25">63038.67</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3967af4e-ec47-45ed-ba18-e6bc60be2045">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-05-01" />
      <value currency="USD" value-date="2023-05-01">90.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="72b5068a-d567-4a7a-8f16-49e07d7bc43f">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-05-02" />
      <value currency="USD" value-date="2023-05-02">3209.12</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d9efc0ef-76a1-49d5-8f5a-762d664b6757">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-03" />
      <value currency="USD" value-date="2023-05-03">100445.73</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a95f8fe2-626f-4e28-b11e-2a08b50cd1dc">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-04" />
      <value currency="USD" value-date="2023-05-04">-90.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8791de87-415b-48de-9fe3-da8b033c31a4">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-23" />
      <value currency="USD" value-date="2023-05-23">1.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b3ca9e19-076b-4b6c-8940-f5543ed271cb">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-23" />
      <value currency="USD" value-date="2023-05-23">869696.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b5cf6424-6416-434f-81a2-34d0c24dcb58">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-25" />
      <value currency="USD" value-date="2023-05-25">-3209.12</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5ff60579-a899-4aeb-b9b3-86ff5b9bc583">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-06-01" />
      <value currency="USD" value-date="2023-06-01">388.68</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f678dfee-8435-478e-9614-8ab54f063b99">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-13" />
      <value currency="USD" value-date="2023-06-13">29694.70</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0333feff-1890-45ef-9e59-07f6b1f6ecf2">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-13" />
      <value currency="USD" value-date="2023-06-13">797673.95</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="73dedb20-ccd5-4404-aedd-e3eb6733ec89">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-29" />
      <value currency="USD" value-date="2023-06-29">240669.07</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e1c1c5fb-12cf-4b1c-91ab-05e1f81f01f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-29" />
      <value currency="USD" value-date="2023-06-29">6354714.97</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f11487dc-2acb-4f13-ab18-fb16b1cb85c8">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-30" />
      <value currency="USD" value-date="2023-06-30">-388.68</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4eb6a961-dddf-4897-800e-e48dd66fa975">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-07-01" />
      <value currency="USD" value-date="2023-07-01">19841.37</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6370fc4-d8f2-48d3-8b68-7dc56cfcd92d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-06" />
      <value currency="USD" value-date="2023-07-06">1687115.94</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c40cce16-3cb0-4af9-af44-a9310c653f2e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-06" />
      <value currency="USD" value-date="2023-07-06">12981.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c8d03eac-fd02-447e-878c-69068ab03692">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-06" />
      <value currency="USD" value-date="2023-07-06">14433.01</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e95f348c-b37b-4b60-8463-1e1d6eb93a98">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-12" />
      <value currency="USD" value-date="2023-07-12">-19841.37</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="91a395b4-5ebf-4ebc-afdc-30cf7f1f3415">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">50000.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="de050ae8-dd3e-46ea-9803-f180c081ed5f">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-08-17" />
      <value currency="USD" value-date="2023-08-17">13593.13</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="00d437d4-a438-4f2a-a692-91ef4d07cdb2">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-23" />
      <value currency="USD" value-date="2023-08-23">99610.44</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="702fccc2-f997-4cc1-9f66-5fa3b6315a56">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-28" />
      <value currency="USD" value-date="2023-08-28">-13593.13</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fc334969-36e5-46bb-a120-1094ff55958d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-31" />
      <value currency="USD" value-date="2023-08-31">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="94a94648-bc32-43cb-81aa-bf36fe4bd64c">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-05" />
      <value currency="USD" value-date="2023-09-05">-236281.92</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="63cf005b-f8ff-48c6-aee3-f4f14b103285">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-05" />
      <value currency="USD" value-date="2023-09-05">18112624.33</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1742d457-e9f3-45cf-b038-e1fe93f968d6">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">1551986.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ce093940-0295-4e1e-aeae-42fe3724fa2b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">4951827.03</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0a49f7e1-6ca4-4ac3-aaa9-b222844d12a0">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-19" />
      <value currency="USD" value-date="2023-09-19">38987.20</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0a63825a-7088-43ea-b200-5fb3b9504aea">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-23" />
      <value currency="USD" value-date="2023-09-23">416870.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2c062af2-b816-4ec2-8bf9-9a1690a82e7e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-17" />
      <value currency="USD" value-date="2023-10-17">49326.70</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="50aba488-6c98-45e1-a7fb-ab7e5ee28ca8">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-24" />
      <value currency="USD" value-date="2023-10-24">3624857.98</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3d8a3894-3a4f-41c0-9a22-6802739a1883">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-24" />
      <value currency="USD" value-date="2023-10-24">12981.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cb9ac7c1-8b29-4762-acbf-f2a5b7525247">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-09" />
      <value currency="USD" value-date="2023-11-09">1486861.65</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3f9cf028-b0fe-491c-8d5c-a8da036c083f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-23" />
      <value currency="USD" value-date="2023-11-23">258937.96</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f93c5afb-3f6f-416f-8765-36435c13c9c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-02" />
      <value currency="USD" value-date="2023-12-02">2998.38</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fddd8299-b089-42d9-84ed-69fee056d25c">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-12-06" />
      <value currency="USD" value-date="2023-12-06">10475.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4b5ecfb4-c247-4afb-8151-5fb6abc8ca35">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-07" />
      <value currency="USD" value-date="2023-12-07">930895.09</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a76f03e8-7e08-44e5-af18-89cc2739f236">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">418025.96</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="651b64d3-49d9-433c-b984-05e20ce174f9">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-20" />
      <value currency="USD" value-date="2023-12-20">-10475.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56924724-275d-4bd2-9015-8aff6a8f3be2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-09" />
      <value currency="USD" value-date="2024-01-09">19346.67</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3a9ff2db-c84c-49c7-a833-448d1c5b1cb2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-09" />
      <value currency="USD" value-date="2024-01-09">-45407.79</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="898cd3e2-fd50-4841-acdc-bd6ab32a4ab3">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-16" />
      <value currency="USD" value-date="2024-01-16">151003.13</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d9b7d80f-f134-4a08-b82e-4b65a9df1836">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-13" />
      <value currency="USD" value-date="2024-02-13">251671.88</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f974f43f-d18b-4375-8e73-7e468131e301">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-11" />
      <value currency="USD" value-date="2024-03-11">-19346.67</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f9e6c5c3-5b98-4c1a-997b-b718198640fe">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-15" />
      <value currency="USD" value-date="2024-03-15">-14194.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea332519-3ad0-49e6-adc1-659c7fa1345b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-15" />
      <value currency="USD" value-date="2024-03-15">11994975.25</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="90803e2e-225f-4e69-99e7-0b1790fb8463">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-19" />
      <value currency="USD" value-date="2024-03-19">21733.42</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="04f96c83-5806-4f17-bf60-3f7808a4993e">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-30" />
      <value currency="USD" value-date="2024-03-30">-11994975.25</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4a238b21-9819-42f4-839a-da15575c22be">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-30" />
      <value currency="USD" value-date="2024-03-30">11980780.26</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a1afd04-0df8-460e-9258-78fb1e942531">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-17" />
      <value currency="USD" value-date="2024-04-17">-11980780.26</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="522ef41a-08d8-40b3-a2c3-2f4146762680">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-17" />
      <value currency="USD" value-date="2024-04-17">39568365.38</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="10ab8338-2ef8-4d59-ab7d-f3c5ec220dd2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-02" />
      <value currency="USD" value-date="2024-05-02">39684190.35</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6b6203ca-0a5e-4c87-b77a-a58a3c3c4699">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-02" />
      <value currency="USD" value-date="2024-05-02">-39568365.38</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0b0ff5f7-46ad-4fbd-983f-ab31debe88bb">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-21" />
      <value currency="USD" value-date="2024-05-21">3337568.19</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9619ab4c-b7d3-452c-b57a-80c058e07357">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-06-12" />
      <value currency="USD" value-date="2024-06-12">3305.62</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="02c81d34-e2c8-4ac9-940b-dfa66dff1617">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-18" />
      <value currency="USD" value-date="2024-06-18">-3305.62</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="52600eaf-3a59-4aff-a261-a96557c072f2">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-01" />
      <value currency="USD" value-date="2024-07-01">21341.80</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2d8cb250-175d-454c-b8b2-20fd2b0667a0">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-04" />
      <value currency="USD" value-date="2024-07-04">-21341.80</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5080a0f2-4dca-4ffd-8d59-25cebc6a16a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-08" />
      <value currency="USD" value-date="2024-08-08">2978886.15</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3aeda3ae-865b-4adc-b487-7b8938db0e8e">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-22" />
      <value currency="USD" value-date="2024-08-22">894310.51</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2684b51f-86fd-4b6e-abcd-82924aed4feb">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-22" />
      <value currency="USD" value-date="2024-08-22">-1516949.82</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d2c1eebd-39f1-48dd-934b-58299dd400ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-27" />
      <value currency="USD" value-date="2024-08-27">409713.94</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="66ee371f-faea-4fdf-99da-bfe312f0cd2e">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-27" />
      <value currency="USD" value-date="2024-08-27">459742.57</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bc0499e6-c8f2-41c4-b030-97b84058c68e">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-27" />
      <value currency="USD" value-date="2024-08-27">24854.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0c978155-5a7c-4dc8-bb37-d5fc9a4f9f3e">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">137320.22</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="da90fc8f-a133-4601-aa85-f0a5b72e14f4">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">-137320.22</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e1ee7340-47fa-4071-ad52-d14fad0d64aa">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-26" />
      <value currency="USD" value-date="2024-09-26">8864632.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3579c952-fac3-438a-823a-0147129202af">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-39690.23</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="11bd42f7-6146-474e-a2b7-2d5e4b5196fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">3146234.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ce521376-96fb-4d55-a482-b900bb2db615">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">39690.23</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="814364c1-9716-46cf-ad06-cb10763afbbd">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">1573117.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8a30eb5b-c4c6-4403-a482-c546a5c1bb16">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-01" />
      <value currency="USD" value-date="2024-11-01">1648307.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6f3c25c1-2d15-44b9-9e57-32a1f74b267e">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-19" />
      <value currency="USD" value-date="2024-11-19">8937242.45</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3203b4f8-3f06-49d8-b59c-e1f87846b8d6">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-09" />
      <value currency="USD" value-date="2025-01-09">1573117.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a1b99b29-2dc4-4835-8e82-4cf5a8e30e53">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-21" />
      <value currency="USD" value-date="2025-01-21">75190.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="13d16d6a-28c7-4bae-9beb-442653d2ead3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-28" />
      <value currency="USD" value-date="2025-01-28">225570.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="640d28d0-5f21-4b93-a935-9c3f2b385d07">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-10" />
      <value currency="USD" value-date="2025-03-10">24404689.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3b10183d-a815-430a-8e09-255e6e36853f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-13" />
      <value currency="USD" value-date="2025-03-13">20423681.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c8f295c6-61d1-4156-b36c-7d9ad2a87209">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-15" />
      <value currency="USD" value-date="2025-04-15">75190.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="23a36e10-b946-46e4-86bf-6ee9fbbcdf85">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-13" />
      <value currency="USD" value-date="2025-05-13">6292468.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4486e05d-64e3-4fa8-87fd-3d085bf4cfa0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">1371717.55</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c2d647e2-a4cb-4e82-b3c7-209feee41731">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-21" />
      <value currency="USD" value-date="2025-06-21">2966752.11</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5fda8f38-9430-4ab0-ac8f-5439e1cec952">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-21" />
      <value currency="USD" value-date="2025-06-21">-44232.91</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="522f1e76-1a7c-4d69-a4c1-674d18631c4f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-21" />
      <value currency="USD" value-date="2025-06-21">-2922519.20</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d5c1c167-deeb-47c4-b0c9-8d8d0d3183bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">2778593.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2ff08b9-a582-4c75-8934-2be530bc4de0">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-42074.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="88df9b0d-bc17-4db6-89d8-b5383bce53b5">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">42074.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="50c53e43-5fec-4d40-8811-522d1279bbf1">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-07-02" />
      <value currency="USD" value-date="2025-07-02">44232.91</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="79ccfb9c-67c0-4b88-91e1-1338115e21a9">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-02" />
      <value currency="USD" value-date="2025-07-02">2866752.11</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e08845f-2bfb-45e4-abe4-891a742437ed">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-02" />
      <value currency="USD" value-date="2025-07-02">-2966752.11</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="75df60e2-8994-49c7-a814-bde60c0d33cf">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-28" />
      <value currency="USD" value-date="2025-08-28">-2866752.11</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="51a5c737-7fe4-4fda-8353-9e69652d82a7">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-28" />
      <value currency="USD" value-date="2025-08-28">3338949.92</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c0b4021d-d6de-4194-b812-29a18319285b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-14" />
      <value currency="USD" value-date="2025-10-14">704215.75</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a0751f92-8b9a-43d8-9359-0861c87098dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">687010.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d77dfa98-31dd-4d00-aa82-21f5a4f4d3af">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">171495.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="90a988bf-8303-4cb8-a038-35d757e61d41">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-14" />
      <value currency="USD" value-date="2025-11-14">1660929.72</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="62912efa-31d5-4927-a2d4-6017b96f5b36">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-14" />
      <value currency="USD" value-date="2025-11-14">-1202415.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="54290302-ff43-4d47-9803-4f72c52a0731">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">1660929.72</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7bd17b0b-f7c6-40c2-a3b1-a5451128c39e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-25" />
      <value currency="USD" value-date="2025-11-25">180250.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="644c97fe-1e8f-4392-a090-37af9e649753">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">1371717.55</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ab4cc8ff-7dc6-44b2-954c-b2e425d3ebbf">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">5673926.82</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8002a084-7013-4697-b86d-bfe9521617fd">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">3137764.27</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="38ae6341-91c7-4c69-80f8-16ccaba7cb7d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">180250.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="87b03c45-1b3d-4534-8a0b-ae911410242f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">12071.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e0f5a705-1e3b-4d81-b740-08e88827d7d1">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">617344.85</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4d23869b-a5fe-4e3c-b8ba-4d68ac2f3549">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-02" />
      <value currency="USD" value-date="2026-02-02">12414.74</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e89a4c7-07f0-4428-ae63-e82042c95f87">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-02" />
      <value currency="USD" value-date="2026-02-02">-44011.62</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1565b24f-5dd1-4e01-b1e6-6da756b3ebec">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-24" />
      <value currency="USD" value-date="2026-02-24">12071.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e987a9f-90ba-456e-a8e4-aba9101bb6cf">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-24" />
      <value currency="USD" value-date="2026-03-24">707513.64</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ee51ed61-c130-44e2-80df-30555fca142d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-09" />
      <value currency="USD" value-date="2026-04-09">12414.73</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="51799615-55ce-451a-9aeb-1f6653b560c9">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-09" />
      <value currency="USD" value-date="2026-04-09">-12414.74</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="356f4de1-28cb-4af9-995b-4f578cfa9740">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">1187162.06</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5872204b-3805-4e9a-899a-31e5421c145b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-19" />
      <value currency="USD" value-date="2026-06-19">-12414.73</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="43519c60-f1d2-443e-8e19-a9fb5944eb32">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-28" />
      <value currency="USD" value-date="2026-09-28">1791357.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="309f42ef-72bf-48a2-a49f-ce2972dda3ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">1791357.61</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="NGA-T-NTBLCPP02-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">18740836.43</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP02, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP02-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">36881110.78</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP02, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP02-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">48412156.70</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP02, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP02-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">5469088.94</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP02, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP02-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">23183552.50</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP02, Jul 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP02-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">24354129.77</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP02, Jan 2025 to Jun 2025.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP02-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">32975357.43</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP02, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/NGA-T-NTBLCP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/NGA/2020/TB_HIV/en/NGA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 1 - TB/HIV - Nigeria - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR733-NGA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-03-23" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 2384.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2316; Denominator: 2384; Percentage: 97.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2316; Denominator: 2384; Percentage: 97.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2316; Denominator: 2384; Percentage: 97.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2316; Denominator: 2384; Percentage: 97.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2316; Denominator: 2384; Percentage: 97.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2316; Denominator: 2384; Percentage: 97.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 68; Denominator: 2384; Percentage: 2.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 68; Denominator: 2384; Percentage: 2.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 68; Denominator: 2384; Percentage: 2.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 68; Denominator: 2384; Percentage: 2.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 68; Denominator: 2384; Percentage: 2.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 68; Denominator: 2384; Percentage: 2.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 868; Denominator: 2384; Percentage: 36.41%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 868; Denominator: 2384; Percentage: 36.41%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 868; Denominator: 2384; Percentage: 36.41%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 868; Denominator: 2384; Percentage: 36.41%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 868; Denominator: 2384; Percentage: 36.41%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 868; Denominator: 2384; Percentage: 36.41%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1516; Denominator: 2384; Percentage: 63.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1516; Denominator: 2384; Percentage: 63.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1516; Denominator: 2384; Percentage: 63.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1516; Denominator: 2384; Percentage: 63.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1516; Denominator: 2384; Percentage: 63.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1516; Denominator: 2384; Percentage: 63.59%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2793.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1405.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1372; Denominator: 1405; Percentage: 97.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 33; Denominator: 1405; Percentage: 2.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 499; Denominator: 1405; Percentage: 35.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 906; Denominator: 1405; Percentage: 64.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5587.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2975.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2794.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1570.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1149; Denominator: 1171; Percentage: 98.12%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 22; Denominator: 1171; Percentage: 1.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 401; Denominator: 1171; Percentage: 34.24%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 770; Denominator: 1171; Percentage: 65.76%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3878.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1970.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1922; Denominator: 1970; Percentage: 97.56%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 48; Denominator: 1970; Percentage: 2.44%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 702; Denominator: 1970; Percentage: 35.63%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1268; Denominator: 1970; Percentage: 64.37%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7757.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3932.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3879.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1962.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1885; Denominator: 1962; Percentage: 96.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 77; Denominator: 1962; Percentage: 3.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 683; Denominator: 1962; Percentage: 34.81%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1279; Denominator: 1962; Percentage: 65.19%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5617.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1950.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1808; Denominator: 1950; Percentage: 92.72%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 142; Denominator: 1950; Percentage: 7.28%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 734; Denominator: 1950; Percentage: 37.64%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1216; Denominator: 1950; Percentage: 62.36%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11235.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5618.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1653.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1586; Denominator: 1653; Percentage: 95.95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 67; Denominator: 1653; Percentage: 4.05%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 559; Denominator: 1653; Percentage: 33.82%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1094; Denominator: 1653; Percentage: 66.18%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 1975.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1925; Denominator: 1975; Percentage: 97.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1925; Denominator: 1975; Percentage: 97.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1925; Denominator: 1975; Percentage: 97.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1925; Denominator: 1975; Percentage: 97.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1925; Denominator: 1975; Percentage: 97.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1925; Denominator: 1975; Percentage: 97.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 50; Denominator: 1975; Percentage: 2.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 50; Denominator: 1975; Percentage: 2.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 50; Denominator: 1975; Percentage: 2.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 50; Denominator: 1975; Percentage: 2.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 50; Denominator: 1975; Percentage: 2.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 50; Denominator: 1975; Percentage: 2.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 699; Denominator: 1975; Percentage: 35.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 699; Denominator: 1975; Percentage: 35.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 699; Denominator: 1975; Percentage: 35.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 699; Denominator: 1975; Percentage: 35.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 699; Denominator: 1975; Percentage: 35.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 699; Denominator: 1975; Percentage: 35.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1276; Denominator: 1975; Percentage: 64.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1276; Denominator: 1975; Percentage: 64.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1276; Denominator: 1975; Percentage: 64.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1276; Denominator: 1975; Percentage: 64.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1276; Denominator: 1975; Percentage: 64.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1276; Denominator: 1975; Percentage: 64.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 143; Denominator: 1975; Percentage: 7.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 143; Denominator: 1975; Percentage: 7.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 143; Denominator: 1975; Percentage: 7.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 143; Denominator: 1975; Percentage: 7.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 143; Denominator: 1975; Percentage: 7.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 1832; Denominator: 1975; Percentage: 92.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 1832; Denominator: 1975; Percentage: 92.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 1832; Denominator: 1975; Percentage: 92.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 1832; Denominator: 1975; Percentage: 92.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 1832; Denominator: 1975; Percentage: 92.76%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2793.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1026.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1010; Denominator: 1026; Percentage: 98.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 16; Denominator: 1026; Percentage: 1.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 340; Denominator: 1026; Percentage: 33.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 686; Denominator: 1026; Percentage: 66.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1026; Denominator: 1026; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1026; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5587.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2197.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2794.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1171.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1536; Denominator: 1570; Percentage: 97.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 34; Denominator: 1570; Percentage: 2.17%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 547; Denominator: 1570; Percentage: 34.84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1023; Denominator: 1570; Percentage: 65.16%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1570; Denominator: 1570; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1570; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3878.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1565.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1542; Denominator: 1565; Percentage: 98.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 23; Denominator: 1565; Percentage: 1.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 523; Denominator: 1565; Percentage: 33.42%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1042; Denominator: 1565; Percentage: 66.58%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 95; Denominator: 1565; Percentage: 6.07%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1470; Denominator: 1565; Percentage: 93.93%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7757.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3183.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3879.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1618.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1560; Denominator: 1618; Percentage: 96.42%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 58; Denominator: 1618; Percentage: 3.58%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 553; Denominator: 1618; Percentage: 34.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1065; Denominator: 1618; Percentage: 65.82%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1618; Denominator: 1618; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1611; Denominator: 1618; Percentage: 99.57%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11235.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3004.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5617.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1594.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1452; Denominator: 1594; Percentage: 91.09%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 142; Denominator: 1594; Percentage: 8.91%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 576; Denominator: 1594; Percentage: 36.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1018; Denominator: 1594; Percentage: 63.86%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5618.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1410.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1366; Denominator: 1410; Percentage: 96.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 44; Denominator: 1410; Percentage: 3.12%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 456; Denominator: 1410; Percentage: 32.34%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 954; Denominator: 1410; Percentage: 67.66%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1410; Denominator: 1410; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1397; Denominator: 1410; Percentage: 99.08%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="58" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="75" />
          <actual value="63">
            <comment>
              <narrative>Numerator: 71317; Denominator: 113156.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="75" />
          <actual value="62" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="75" />
          <actual value="63">
            <comment>
              <narrative>Numerator: 71317; Denominator: 113156.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="80" />
          <actual value="65.3">
            <comment>
              <narrative>Numerator: 85376; Denominator: 130679.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="80" />
          <actual value="68">
            <comment>
              <narrative>Numerator: 194234; Denominator: 285563.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="80" />
          <actual value="70.3">
            <comment>
              <narrative>Numerator: 108858; Denominator: 154884.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="80" />
          <actual value="71" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80" />
          <actual value="73">
            <comment>
              <narrative>Numerator: 148854; Denominator: 203828.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80" />
          <actual value="73">
            <comment>
              <narrative>Numerator: 148854; Denominator: 203828.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>PSM - Other 1: Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health products management systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>PSM - Other 1: Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="95">
          <comment>
            <narrative>Numerator: 11976; Denominator: 12606.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 24708; Denominator: 25212.</narrative>
            </comment>
          </target>
          <actual value="94.4">
            <comment>
              <narrative>Numerator: 11399; Denominator: 12076.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="98">
            <comment>
              <narrative>Numerator: 12354; Denominator: 12606.</narrative>
            </comment>
          </target>
          <actual value="95" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 12354; Denominator: 12606.</narrative>
            </comment>
          </target>
          <actual value="94.4">
            <comment>
              <narrative>Numerator: 11399; Denominator: 12076.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 12480; Denominator: 12606.</narrative>
            </comment>
          </target>
          <actual value="95.8">
            <comment>
              <narrative>Numerator: 12744; Denominator: 13301.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 24960; Denominator: 25212.</narrative>
            </comment>
          </target>
          <actual value="95.7">
            <comment>
              <narrative>Numerator: 24911; Denominator: 26041.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 12480; Denominator: 12606.</narrative>
            </comment>
          </target>
          <actual value="95.5">
            <comment>
              <narrative>Numerator: 12167; Denominator: 12740.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 12606; Denominator: 12606.</narrative>
            </comment>
          </target>
          <actual value="95.6">
            <comment>
              <narrative>Numerator: 12456; Denominator: 13028.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 25212; Denominator: 25212.</narrative>
            </comment>
          </target>
          <actual value="95.6">
            <comment>
              <narrative>Numerator: 12456; Denominator: 13028.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 12606; Denominator: 12606.</narrative>
            </comment>
          </target>
          <actual value="95" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="26226" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="39086" />
          <actual value="68319" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="19543" />
          <actual value="27735" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="19543" />
          <actual value="40584" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="25406" />
          <actual value="53028" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="50812" />
          <actual value="122847" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="25406" />
          <actual value="69819" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="69498" />
          <actual value="158512" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="34749" />
          <actual value="76815" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="34749" />
          <actual value="81697" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="17250" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="54721" />
          <actual value="58420" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="27360" />
          <actual value="27427" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="27361" />
          <actual value="30993" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="34200" />
          <actual value="31246" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="68401" />
          <actual value="69474" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="34201" />
          <actual value="38228" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90090" />
          <actual value="108514" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="45045" />
          <actual value="44354" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="45045" />
          <actual value="64160" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 120266.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3387.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3387.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3387.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3387.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3387.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3387.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 86378.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 86378.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 86378.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 86378.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 86378.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 86378.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 9540.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 9540.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 9540.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 9540.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 9540.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 9540.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 104358.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 104358.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 104358.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 104358.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 104358.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 104358.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 73665.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 73665.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 73665.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 73665.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 73665.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 73665.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 110726.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 110726.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 110726.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 110726.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 110726.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 110726.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 46601.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 46601.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 46601.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 46601.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 46601.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 46601.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 78173.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 94739.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 88988; Denominator: 94739; Percentage: 93.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 5715; Denominator: 94739; Percentage: 6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 72682; Denominator: 94739; Percentage: 76.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 37526; Denominator: 94739; Percentage: 39.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 57213; Denominator: 94739; Percentage: 60.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 85804; Denominator: 94739; Percentage: 90.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 3420; Denominator: 94739; Percentage: 3.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 5515; Denominator: 94739; Percentage: 5.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 156346.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 207895.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 78173.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 113156.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 111025; Denominator: 113156; Percentage: 98.12%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2131; Denominator: 113156; Percentage: 1.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 87344; Denominator: 113156; Percentage: 77.19%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 46176; Denominator: 113156; Percentage: 40.81%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 66980; Denominator: 113156; Percentage: 59.19%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 103360; Denominator: 113156; Percentage: 91.34%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 3204; Denominator: 113156; Percentage: 2.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 6592; Denominator: 113156; Percentage: 5.83%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 97716.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 130679.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 122335; Denominator: 130679; Percentage: 93.61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 8344; Denominator: 130679; Percentage: 6.39%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 104326; Denominator: 130679; Percentage: 79.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 53804; Denominator: 130679; Percentage: 41.17%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 76875; Denominator: 130679; Percentage: 58.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 117564; Denominator: 130679; Percentage: 89.96%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 4702; Denominator: 130679; Percentage: 3.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 8413; Denominator: 130679; Percentage: 6.44%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 195432.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 285563.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 97716.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 154884.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 142817; Denominator: 154884; Percentage: 92.21%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 12067; Denominator: 154884; Percentage: 7.79%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 123896; Denominator: 154884; Percentage: 79.99%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 66042; Denominator: 154884; Percentage: 42.64%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 88842; Denominator: 154884; Percentage: 57.36%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 143999; Denominator: 154884; Percentage: 92.97%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 3182; Denominator: 154884; Percentage: 2.05%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 7703; Denominator: 154884; Percentage: 4.97%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 128700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 167002.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 150655; Denominator: 167002; Percentage: 90.21%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 16281; Denominator: 167002; Percentage: 9.75%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 134873; Denominator: 167002; Percentage: 80.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 70652; Denominator: 167002; Percentage: 42.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 96284; Denominator: 167002.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 154827; Denominator: 167002; Percentage: 92.71%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 3974; Denominator: 167002; Percentage: 2.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 8135; Denominator: 167002.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 257400.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 370835.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 128700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 203833.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 183972; Denominator: 203833; Percentage: 90.26%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 19861; Denominator: 203833; Percentage: 9.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 168084; Denominator: 203833; Percentage: 82.46%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 87746; Denominator: 203833; Percentage: 43.05%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 116087; Denominator: 203833; Percentage: 56.95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 187303; Denominator: 203833; Percentage: 91.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 6565; Denominator: 203833; Percentage: 3.22%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 9965; Denominator: 203833; Percentage: 4.89%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 10788.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 9772.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 9772.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 9772.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1016.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1016.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1016.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1016.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1016.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1016.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 106103.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7011.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1207; Denominator: 7011; Percentage: 17.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 5804; Denominator: 7011; Percentage: 82.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 212206.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17584.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 106103.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10573.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 7359; Denominator: 10573; Percentage: 69.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 130547.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 37464.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 25651; Denominator: 37464; Percentage: 68.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 11813; Denominator: 37464; Percentage: 31.53%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 261095.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 106333.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 130548.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 68869.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 20759; Denominator: 68869; Percentage: 30.14%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 148350.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 116082.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 30205.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 296701.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 290571.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 148351.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 174489.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 50998; Denominator: 174489; Percentage: 29.23%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="97.98">
          <comment>
            <narrative>Numerator: 3155; Denominator: 3220.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3155; Denominator: 3220.</narrative>
            </comment>
          </target>
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 1565; Denominator: 1671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="97.98">
            <comment>
              <narrative>Numerator: 3155; Denominator: 3220.</narrative>
            </comment>
          </target>
          <actual value="62">
            <comment>
              <narrative>Numerator: 1687; Denominator: 2719.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="97.98">
            <comment>
              <narrative>Numerator: 3155; Denominator: 3220.</narrative>
            </comment>
          </target>
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 1565; Denominator: 1671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="97.98">
            <comment>
              <narrative>Numerator: 3155; Denominator: 3220.</narrative>
            </comment>
          </target>
          <actual value="95.5">
            <comment>
              <narrative>Numerator: 1654; Denominator: 1732.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3155; Denominator: 3155.</narrative>
            </comment>
          </target>
          <actual value="93.4">
            <comment>
              <narrative>Numerator: 1679; Denominator: 1797.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="97.98">
            <comment>
              <narrative>Numerator: 3155; Denominator: 3155.</narrative>
            </comment>
          </target>
          <actual value="93.4">
            <comment>
              <narrative>Numerator: 1679; Denominator: 1797.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="98.01">
            <comment>
              <narrative>Numerator: 3156; Denominator: 3220.</narrative>
            </comment>
          </target>
          <actual value="86.3">
            <comment>
              <narrative>Numerator: 1605; Denominator: 1859.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3156; Denominator: 3220.</narrative>
            </comment>
          </target>
          <actual value="94">
            <comment>
              <narrative>Numerator: 1529; Denominator: 1619.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="98.01">
            <comment>
              <narrative>Numerator: 3156; Denominator: 3220.</narrative>
            </comment>
          </target>
          <actual value="94">
            <comment>
              <narrative>Numerator: 1529; Denominator: 1619.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="87" />
        <baseline year="2019" iso-date="2019-12-31" value="75.84">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9632; Denominator: 12700.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="75.84">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9632; Denominator: 12700.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="75.84">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9632; Denominator: 12700.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="75.84">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9632; Denominator: 12700.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90" />
          <actual value="87" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90" />
          <actual value="90" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90" />
          <actual value="90" />
          <actual value="60.18">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 42248; Denominator: 70205.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90" />
          <actual value="90.7">
            <comment>
              <narrative>Numerator: 188402; Denominator: 207785.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90" />
          <actual value="89.8">
            <comment>
              <narrative>Numerator: 84964; Denominator: 94629.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90" />
          <actual value="91.4">
            <comment>
              <narrative>Numerator: 103438; Denominator: 113156.</narrative>
            </comment>
          </actual>
          <actual value="59.01">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 61041; Denominator: 103438.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90" />
          <actual value="92" />
          <actual value="58">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90" />
          <actual value="93" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90" />
          <actual value="93" />
          <actual value="57.02">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 82166; Denominator: 144092.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="91.21">
          <comment>
            <narrative>Numerator: 11420; Denominator: 12521.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100" />
          <actual value="92" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100" />
          <actual value="92" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100" />
          <actual value="92" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100" />
          <actual value="90.8">
            <comment>
              <narrative>Numerator: 14235; Denominator: 15679.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100" />
          <actual value="90.6">
            <comment>
              <narrative>Numerator: 7425; Denominator: 8197.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100" />
          <actual value="91">
            <comment>
              <narrative>Numerator: 6810; Denominator: 7482.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100" />
          <actual value="93.1">
            <comment>
              <narrative>Numerator: 16396; Denominator: 17611.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100" />
          <actual value="93.2">
            <comment>
              <narrative>Numerator: 7345; Denominator: 7880.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100" />
          <actual value="93">
            <comment>
              <narrative>Numerator: 9051; Denominator: 9731.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="97" />
        <baseline year="2019" iso-date="2019-12-31" value="94.44">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 11825; Denominator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="94.44">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 11825; Denominator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="4.06">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 508; Denominator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="4.06">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 508; Denominator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1.5">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 188; Denominator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1.5">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 188; Denominator: 12521.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="38.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 45297; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="38.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 45297; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="38.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 45297; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="38.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 45297; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="38.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 45297; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="38.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 45297; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="61.24">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 71582; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="61.24">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 71582; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="61.24">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 71582; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="61.24">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 71582; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="61.24">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 71582; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="61.24">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 71582; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="10.71">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 12521; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="10.71">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 12521; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="10.71">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 12521; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="10.71">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 12521; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="10.71">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 12521; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="10.71">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 12521; Denominator: 116879.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100" />
          <actual value="97" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100" />
          <actual value="96" />
          <actual value="95.2">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5253; Denominator: 5515.</narrative>
            </comment>
          </actual>
          <actual value="3.4">
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 189; Denominator: 5515.</narrative>
            </comment>
          </actual>
          <actual value="1.3">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 73; Denominator: 5515.</narrative>
            </comment>
          </actual>
          <actual value="39.8">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 35708; Denominator: 89716.</narrative>
            </comment>
          </actual>
          <actual value="60.2">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 54008; Denominator: 89716.</narrative>
            </comment>
          </actual>
          <actual value="5.9">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 5327; Denominator: 89716.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100" />
          <actual value="97" />
          <actual value="39.81">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 44437; Denominator: 111615.</narrative>
            </comment>
          </actual>
          <actual value="57.35">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 64008; Denominator: 111615.</narrative>
            </comment>
          </actual>
          <actual value="3.71">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 4143; Denominator: 111615.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100" />
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 124356; Denominator: 125977.</narrative>
            </comment>
          </actual>
          <actual value="40.57">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 51103; Denominator: 125977.</narrative>
            </comment>
          </actual>
          <actual value="58.57">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 73253; Denominator: 125077.</narrative>
            </comment>
          </actual>
          <actual value="6.51">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 8197; Denominator: 125977.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100" />
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 124356; Denominator: 125977.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100" />
          <actual value="98" />
          <actual value="42.75">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 64054; Denominator: 149843.</narrative>
            </comment>
          </actual>
          <actual value="57.25">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 85789; Denominator: 149843.</narrative>
            </comment>
          </actual>
          <actual value="4.99">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 7482; Denominator: 149843.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100" />
          <actual value="98" />
          <actual value="42.34">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 68154; Denominator: 160963.</narrative>
            </comment>
          </actual>
          <actual value="57.66">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 92809; Denominator: 160963.</narrative>
            </comment>
          </actual>
          <actual value="4.9">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 7880; Denominator: 160963.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100" />
          <actual value="97" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100" />
          <actual value="97" />
          <actual value="42.91">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 84649; Denominator: 197268.</narrative>
            </comment>
          </actual>
          <actual value="57.09">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 112619; Denominator: 197268.</narrative>
            </comment>
          </actual>
          <actual value="4.93">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 9731; Denominator: 197268.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-NGA-T-NTBLCP-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for Impact Against Tuberculosis - Nigeria (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Nigeria, Tuberculosis, National Tuberculosis &amp; Leprosy Control Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To accelerate efforts at ending TB epidemic in Nigeria by ensuring access to comprehensive and high quality patients' centered and community owned TB (TB. TB/HIV and DR-TB) services for all Nigerians by 2026. Objectives: To increase case notification rate of all forms of TB from 131/100,000 population in 2022 to 142/100,000 population in 2026; To sustain TB treatment success rate beyond the NSP 2021-2026 target of 90% during the grant period; To enrol 100% of diagnosed DR-TB patients on appropriate treatment by 2026.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="15" role="2" crs-channel-code="12004">
      <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
    </participating-org>
    <participating-org type="15" role="4" crs-channel-code="12004">
      <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
    </participating-org>
    <other-identifier ref="NGA-T-NTBLCPP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="NG" percentage="100">
      <narrative>Nigeria</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="83.45">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="16.55">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="0.35">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="5.7">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="dbf27095-3379-4518-8890-897d22a754ef" percentage="3.17">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Network optimization and geospatial analysis</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="0.47">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="4.6">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="2.26">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="0.43">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="1.26">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="7.12">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="2.1">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="0.14">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="3.49">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
      <budget-item code="2f74d6d7-267e-4393-87f1-d47588e1025c" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Monitoring and reforming policies, regulations and laws</narrative>
        </description>
      </budget-item>
      <budget-item code="24043b35-97d4-4fe5-ba14-64ab665ff4f2" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Reducing TB-related gender discrimination, harmful gender norms and violence</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="35.55">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="32.79">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="0.5">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">21275867.11</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">60055749.78</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">32515502.13</value>
    </budget>
    <capital-spend percentage="11.19" />
    <transaction ref="8b9f3808-2edc-423b-9af7-5d87e693f245">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-01" />
      <value currency="USD" value-date="2023-12-01">5580997.88</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="33642952-770e-4fbc-b84c-7a800e0aa1d9">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-01" />
      <value currency="USD" value-date="2023-12-01">5580997.88</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="003bfb25-7cef-4826-84b3-6779bf679594">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-20" />
      <value currency="USD" value-date="2023-12-20">38508777.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0941fcb7-39ba-40c7-886e-90083c2195b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-21" />
      <value currency="USD" value-date="2023-12-21">1902004.81</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c7ac363d-07ca-4604-a172-aa5029e3ba76">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-16" />
      <value currency="USD" value-date="2024-05-16">1231333.94</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2ad379aa-e572-4509-beb4-45dbcd5136ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-16" />
      <value currency="USD" value-date="2024-05-16">15181830.57</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="67e8acfa-6241-4839-9d08-ea6480b26e61">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">2091654.35</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0ef7409b-6511-4ccd-a3e5-13a0c8d7b137">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">9439956.03</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="79bfc341-0153-443e-aa3e-0f8cbc279ec7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-22" />
      <value currency="USD" value-date="2024-08-22">733049.92</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f93b535f-b463-48a1-b81e-e049d9f0a6ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-22" />
      <value currency="USD" value-date="2024-08-22">869696.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c57f9535-c721-47d3-b5a4-59de14d02910">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-22" />
      <value currency="USD" value-date="2024-10-22">5668857.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6e0a6a6-80df-4934-962c-ffb7395afd3b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-04" />
      <value currency="USD" value-date="2024-11-04">-1390394.38</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5f24f0e0-a4b5-45d2-a139-d5b201508d1d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-04" />
      <value currency="USD" value-date="2024-11-04">8892915.39</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="048efb2f-32dc-4e70-978a-658965e664e7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-07" />
      <value currency="USD" value-date="2024-11-07">1424994.28</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7d5563f6-86d7-4b63-b0ff-6c420288b178">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-07" />
      <value currency="USD" value-date="2024-11-07">7467921.11</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="61d627cd-b104-4c19-b88f-6c8f96433d04">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-16" />
      <value currency="USD" value-date="2024-12-16">3122506.55</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e9e498c0-5395-4b0d-aa22-b5e289b19c27">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-16" />
      <value currency="USD" value-date="2025-01-16">3122506.55</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3db2e77e-0b65-4ad2-81cf-1ee376537e65">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-16" />
      <value currency="USD" value-date="2025-01-16">-3122506.55</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b332256f-c522-46bb-a8f2-ad6e85274084">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-21" />
      <value currency="USD" value-date="2025-01-21">3122506.55</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="07ee1024-024e-46bb-8f29-4e46f67476c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-20" />
      <value currency="USD" value-date="2025-03-20">6542719.73</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="84b5f5b6-bb37-4851-a63f-e9499c801f21">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-25" />
      <value currency="USD" value-date="2025-03-25">6542719.73</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="75af1d96-6fb3-433f-aaeb-bd2aca3395d1">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-01" />
      <value currency="USD" value-date="2025-06-01">105785.55</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9d6094a6-a771-42ac-a85f-703b95447729">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-06" />
      <value currency="USD" value-date="2025-06-06">-105785.55</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3e5fe4d1-c2d9-4c35-b0fa-c28cc328a05f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-07" />
      <value currency="USD" value-date="2025-06-07">10166480.40</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0cc57b5b-851f-4cd9-af4a-31ef6c992f02">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">1155331.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="660d8d72-58e3-49f6-a9ce-b34013e4cddb">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">1166076.63</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="56c27f92-db2b-454a-b0af-b0c7bfa1beab">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">869696.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ddfeb671-142e-4ced-b0b0-9963cb724fbb">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">12427.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0dba6455-3f1f-4c93-99ad-b8e46c42e1d5">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">42074.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7d0fe550-10f0-4660-91c2-21ad3eed37e4">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">42074.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a7696aa8-49f5-44c0-be63-b7ad78da4031">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">23515.24</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0f13a225-5558-4311-a0f4-ff3a64d53dcc">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">3612227.17</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6b0c43a2-3c7d-47e4-8d31-62f0ac5909ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">3324540.76</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="604db41b-4b6e-48b1-b394-0039284d84bf">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-01" />
      <value currency="USD" value-date="2025-09-01">38152.96</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aabb199f-cbec-44ca-8d51-20e6c9f71d01">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-15" />
      <value currency="USD" value-date="2025-09-15">-38152.96</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bf9a0a54-4419-480d-8896-0dfd257be6ac">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-14" />
      <value currency="USD" value-date="2025-11-14">2218859.71</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="46de296c-d2aa-4dd8-a77a-b9213de85f99">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-14" />
      <value currency="USD" value-date="2025-11-14">-2666.60</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2a224cbe-19bc-4435-8887-644093f80200">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">2203767.11</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="10343452-22f0-4a34-9d3e-1c0c15b8f901">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">12426.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1196ebb1-1400-4066-9739-902759ad4710">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">-2666.60</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="011ce6e7-77c8-4ac0-85ac-75aef2abc481">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">781195.13</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="167a889e-b5ff-4cc5-964d-b45fb9e63ba8">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">778528.53</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6246665e-1ed0-468c-8f0b-453fbbd1ed06">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-08" />
      <value currency="USD" value-date="2026-02-08">-2666.60</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="043e6791-ca56-467e-bef9-5d6ffb4e8aa8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-08" />
      <value currency="USD" value-date="2026-02-08">14747044.42</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f7083422-71cb-4dc7-8001-eb50a7f9007c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-17" />
      <value currency="USD" value-date="2026-02-17">4106970.46</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e3a4880c-cda6-4e2c-9c9a-e51386f277c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-17" />
      <value currency="USD" value-date="2026-02-17">9767711.36</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8da01f81-69b9-4e7b-a676-9b3495118e33">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-24" />
      <value currency="USD" value-date="2026-02-24">869696.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5361e3de-94f0-4559-8eb8-7c456bd3ffe5">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-01" />
      <value currency="USD" value-date="2026-03-01">62495.29</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="007cc026-bd05-4588-b13c-a65d40cf24a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-12" />
      <value currency="USD" value-date="2026-03-12">-62495.29</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d45ee8ec-da90-44ef-81d7-166447af80ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-16" />
      <value currency="USD" value-date="2026-04-16">407000.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="72da23ec-cd3c-4ae3-ba91-e5fb5a8bf1de">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-07" />
      <value currency="USD" value-date="2026-05-07">13205162.80</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e6d881f-1ee4-4ade-8721-a92ecb27b839">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-07" />
      <value currency="USD" value-date="2026-05-07">-2666.60</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="461cd01e-0142-4a81-8f5c-67b687acd70e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-12" />
      <value currency="USD" value-date="2026-05-12">4693862.25</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="41fb2543-abf3-4a7d-85dc-003e8067a1cd">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-12" />
      <value currency="USD" value-date="2026-05-12">5044055.58</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ec4d76ef-4e14-4fed-96f4-3f6ef8dc24f9">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-06-01" />
      <value currency="USD" value-date="2026-06-01">491604.53</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d0273295-4b08-498d-95ca-ae53a58b67b1">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-06-04" />
      <value currency="USD" value-date="2026-06-04">465717.68</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="82e18a68-fd30-41c9-ac1b-b43baa729440">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-08" />
      <value currency="USD" value-date="2026-06-08">-491604.53</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d2d1b738-ec6a-4ef7-9a1d-bbadc421cfe5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">485516.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="74559d66-3f6a-4965-aa82-08dcbc44b23c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-19" />
      <value currency="USD" value-date="2026-06-19">-465717.68</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9a3f28dc-58bd-4581-9942-62ebec6565d9">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">1633529.29</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5e6c9e99-c94c-4303-ae34-25707de7e64a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-04" />
      <value currency="USD" value-date="2026-09-04">-1348199.68</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="322f927f-62ee-466b-81ef-93f155e3b6a6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-04" />
      <value currency="USD" value-date="2026-09-04">12824385.95</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a97a3c40-ef36-4f27-869b-76df9f19e0f0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-08" />
      <value currency="USD" value-date="2026-09-08">1982110.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="25cf7709-d426-48d1-9d17-29a4ab297ade">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-08" />
      <value currency="USD" value-date="2026-09-08">9494076.27</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6f906ad1-0ebf-44de-aac1-198421339bbb">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-13" />
      <value currency="USD" value-date="2026-10-13">109324.67</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0ecfdfba-aba9-404a-93ca-78c237be0b31">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-29" />
      <value currency="USD" value-date="2026-10-29">-1238875.01</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="03151230-9377-4331-be2d-984b33c622f9">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-29" />
      <value currency="USD" value-date="2026-10-29">1958179.33</value>
      <description>
        <narrative>Global Fund commitment to NGA-T-NTBLCPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f1627353-0a89-4183-bca2-afaa2572735f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-03" />
      <value currency="USD" value-date="2026-11-03">1933179.33</value>
      <description>
        <narrative>Global Fund disbursement to NGA-T-NTBLCPP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="NGA-T-NTBLCPP03-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">21275243.47</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP03, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-T-NTBLCPP03-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">34180180.00</value>
      <description>
        <narrative>Expenditure reported by National Tuberculosis &amp; Leprosy Control Programme for NGA-T-NTBLCPP03, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National Tuberculosis &amp; Leprosy Control Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/NGA-T-NTBLCP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/NGA/2023/TB_HIV/en/NGA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - TB/HIV - Nigeria - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1535-NGA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
      </title>
      <description>
        <narrative>Module: Collaboration with other providers and sectors.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="92">
          <comment>
            <narrative>Numerator: 53496; Denominator: 58219.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 41561; Denominator: 44690.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 83123; Denominator: 89380.</narrative>
            </comment>
          </target>
          <actual value="94.52">
            <comment>
              <narrative>Numerator: 102585; Denominator: 108530.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 41562; Denominator: 44690.</narrative>
            </comment>
          </target>
          <actual value="94.77">
            <comment>
              <narrative>Numerator: 60806; Denominator: 64164.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 45790; Denominator: 49237.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 91581; Denominator: 98474.</narrative>
            </comment>
          </target>
          <actual value="94.45">
            <comment>
              <narrative>Numerator: 127436; Denominator: 134923.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 45791; Denominator: 49237.</narrative>
            </comment>
          </target>
          <actual value="94.42">
            <comment>
              <narrative>Numerator: 60550; Denominator: 64131.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 56678; Denominator: 60944.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 56678; Denominator: 60944.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 3932.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3782; Denominator: 3932; Percentage: 96.19%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3782; Denominator: 3932; Percentage: 96.19%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 150; Denominator: 3932; Percentage: 3.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 150; Denominator: 3932; Percentage: 3.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1385; Denominator: 3932; Percentage: 35.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1385; Denominator: 3932; Percentage: 35.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2547; Denominator: 3932; Percentage: 64.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2547; Denominator: 3932; Percentage: 64.78%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2666.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5333.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3662.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2667.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1806.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3516.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 146.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1243.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2419.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3056.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6112.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3176.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3056.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1564.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3034.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 142.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1093.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2083.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3474.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3474.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="90">
          <comment>
            <narrative>Numerator: 9; Denominator: 10.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9; Denominator: 10.</narrative>
            </comment>
          </target>
          <actual value="93.09">
            <comment>
              <narrative>Numerator: 957; Denominator: 1028.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9; Denominator: 10.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9; Denominator: 10.</narrative>
            </comment>
          </target>
          <actual value="93.09">
            <comment>
              <narrative>Numerator: 957; Denominator: 1028.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9; Denominator: 10.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9; Denominator: 10.</narrative>
            </comment>
          </target>
          <actual value="70">
            <comment>
              <narrative>Numerator: 7; Denominator: 10.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9; Denominator: 10.</narrative>
            </comment>
          </target>
          <actual value="70">
            <comment>
              <narrative>Numerator: 7; Denominator: 10.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9; Denominator: 10.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9; Denominator: 10.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="68">
          <comment>
            <narrative>Numerator: 194297; Denominator: 285561.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 239410; Denominator: 319213.</narrative>
            </comment>
          </target>
          <actual value="70.38">
            <comment>
              <narrative>Numerator: 285282; Denominator: 405324.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="75">
            <comment>
              <narrative>Numerator: 119705; Denominator: 159606.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 119705; Denominator: 159607.</narrative>
            </comment>
          </target>
          <actual value="69.33">
            <comment>
              <narrative>Numerator: 136049; Denominator: 196239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 131299; Denominator: 164123.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 262598; Denominator: 328247.</narrative>
            </comment>
          </target>
          <actual value="61.29">
            <comment>
              <narrative>Numerator: 281044; Denominator: 458534.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 131299; Denominator: 164124.</narrative>
            </comment>
          </target>
          <actual value="58.1">
            <comment>
              <narrative>Numerator: 140267; Denominator: 241433.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 139301; Denominator: 174126.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 139301; Denominator: 174126.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 3185; Denominator: 3932; Percentage: 81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3065; Denominator: 3185; Percentage: 96.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3065; Denominator: 3185; Percentage: 96.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 120; Denominator: 3185; Percentage: 3.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 120; Denominator: 3185; Percentage: 3.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1076; Denominator: 3185; Percentage: 33.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1076; Denominator: 3185; Percentage: 33.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 32; Denominator: 3185; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 32; Denominator: 3185; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2109; Denominator: 3185; Percentage: 66.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2109; Denominator: 3185; Percentage: 66.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 3153; Denominator: 3185; Percentage: 99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 3153; Denominator: 3185; Percentage: 99%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2667; Denominator: 2667; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3112; Denominator: 3662; Percentage: 84.98%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2666; Denominator: 2666; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2667; Denominator: 2667; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3112; Denominator: 3662; Percentage: 84.98%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2994; Denominator: 3112; Percentage: 96.21%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 118; Denominator: 3112; Percentage: 3.79%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1024; Denominator: 3112; Percentage: 32.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2088; Denominator: 3112; Percentage: 67.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 3092.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3056; Denominator: 3056; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3056; Denominator: 3056; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2827; Denominator: 3176; Percentage: 89.01%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3056; Denominator: 3056; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2827; Denominator: 3176; Percentage: 89.01%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2706; Denominator: 3034; Percentage: 89.19%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 121; Denominator: 142; Percentage: 85.21%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 974; Denominator: 2827; Percentage: 34.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1853; Denominator: 2827; Percentage: 65.55%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3474; Denominator: 3474; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3474; Denominator: 3474; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1238; Denominator: 1492; Percentage: 82.98%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 81; Denominator: 92; Percentage: 88.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 81; Denominator: 92; Percentage: 88.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 1157; Denominator: 1400; Percentage: 82.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 1157; Denominator: 1400; Percentage: 82.64%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2213; Denominator: 2666; Percentage: 83.01%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4426; Denominator: 5333; Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2429; Denominator: 3185; Percentage: 76.26%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2213; Denominator: 2667; Percentage: 82.98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1233; Denominator: 1618; Percentage: 76.21%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 2402.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2536; Denominator: 3056; Percentage: 82.98%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5073; Denominator: 6112; Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2641; Denominator: 3047; Percentage: 86.68%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2537; Denominator: 3056; Percentage: 83.02%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1199; Denominator: 1410; Percentage: 85.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2883; Denominator: 3474; Percentage: 82.99%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2884; Denominator: 3474; Percentage: 83.02%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1210; Denominator: 285561; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1597.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1146.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 798.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 799.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 719.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 820.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1641.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1824.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 821.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 725.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 870.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 871.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 285561.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 265150; Denominator: 285561; Percentage: 92.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 265150; Denominator: 285561; Percentage: 92.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20411; Denominator: 285561; Percentage: 7.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20411; Denominator: 285561; Percentage: 7.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 228224; Denominator: 285561; Percentage: 79.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 228224; Denominator: 285561; Percentage: 79.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 119841; Denominator: 285561; Percentage: 41.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 119841; Denominator: 285561; Percentage: 41.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 165720; Denominator: 285561; Percentage: 58.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 165720; Denominator: 285561; Percentage: 58.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 216606; Denominator: 285561; Percentage: 75.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 216606; Denominator: 285561; Percentage: 75.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 16121; Denominator: 285561; Percentage: 5.65%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 16121; Denominator: 285561; Percentage: 5.65%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 7834; Denominator: 285561; Percentage: 2.74%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 7834; Denominator: 285561; Percentage: 2.74%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 344547.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 401900.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 172273.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 172274.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 194635.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 358255.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 43645.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 326009.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 166563.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 235337.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 375101.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 18976.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 7823.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 375139.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 458534.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 187569.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 187570.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 241433.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 411582.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 46952.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 196475.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 262059.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 442332.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 16202.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 200914.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 200915.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 198870; Denominator: 282043; Percentage: 70.51%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 48790; Denominator: 68682; Percentage: 71.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 48790; Denominator: 68682; Percentage: 71.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 198870; Denominator: 282043; Percentage: 70.51%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 198870; Denominator: 282043; Percentage: 70.51%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 78%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 282826; Denominator: 401900; Percentage: 70.37%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 78%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 78%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 135044; Denominator: 194635; Percentage: 69.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 97527.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 185299.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 359361; Denominator: 458534; Percentage: 78.37%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 83%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 188764; Denominator: 241433; Percentage: 78.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 83%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="43">
          <comment>
            <narrative>Numerator: 122933; Denominator: 285561.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="45">
            <comment>
              <narrative>Numerator: 155058.4; Denominator: 344574.</narrative>
            </comment>
          </target>
          <actual value="37.04">
            <comment>
              <narrative>Numerator: 148849; Denominator: 401900.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="45">
            <comment>
              <narrative>Numerator: 77529.15; Denominator: 172287.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="45">
            <comment>
              <narrative>Numerator: 77529.15; Denominator: 172287.</narrative>
            </comment>
          </target>
          <actual value="39.89">
            <comment>
              <narrative>Numerator: 76915; Denominator: 192815.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="45">
            <comment>
              <narrative>Numerator: 84406.27; Denominator: 187569.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="45">
            <comment>
              <narrative>Numerator: 168812.6; Denominator: 375139.</narrative>
            </comment>
          </target>
          <actual value="40.25">
            <comment>
              <narrative>Numerator: 184567; Denominator: 458534.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="45">
            <comment>
              <narrative>Numerator: 84406.27; Denominator: 187569.5.</narrative>
            </comment>
          </target>
          <actual value="41.48">
            <comment>
              <narrative>Numerator: 100147; Denominator: 241433.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="45">
            <comment>
              <narrative>Numerator: 90411.52; Denominator: 200914.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="45">
            <comment>
              <narrative>Numerator: 90411.52; Denominator: 200914.5.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 69501; Denominator: 285561; Percentage: 24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 55352.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 55352.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 48240.36; Denominator: 172287; Percentage: 28%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 96480.8; Denominator: 344574; Percentage: 28%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 134923; Denominator: 401900; Percentage: 33.57%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 48240.36; Denominator: 172287; Percentage: 28%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 64131; Denominator: 194635; Percentage: 32.95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 107892.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 56270.85; Denominator: 187569.5; Percentage: 30%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 112541.8; Denominator: 375139; Percentage: 30%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 154967; Denominator: 458534; Percentage: 33.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 56270.85; Denominator: 187569.5; Percentage: 30%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 82092; Denominator: 241433; Percentage: 34%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 70320.07; Denominator: 200914.5; Percentage: 35%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 70320.07; Denominator: 200914.5; Percentage: 35%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="91">
          <comment>
            <narrative>Numerator: 188799; Denominator: 207785.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="90.26">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 175826; Denominator: 194808.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="90.26">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 175826; Denominator: 194808.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="92.07">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 11948; Denominator: 12977.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="92.07">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 11948; Denominator: 12977.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="90.97">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 76095; Denominator: 83644.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="90.97">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 76095; Denominator: 83644.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="89.96">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 111679; Denominator: 124141.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="89.96">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 111679; Denominator: 124141.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="87.37">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 165184; Denominator: 189064.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="87.37">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 165184; Denominator: 189064.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="80.47">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 9734; Denominator: 12097.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="80.47">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 9734; Denominator: 12097.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="91">
            <comment>
              <narrative>Numerator: 145242; Denominator: 159606.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 290484; Denominator: 319213.</narrative>
            </comment>
          </target>
          <actual value="93.91">
            <comment>
              <narrative>Numerator: 348417; Denominator: 371019.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 145242; Denominator: 159607.</narrative>
            </comment>
          </target>
          <actual value="93.98">
            <comment>
              <narrative>Numerator: 191409; Denominator: 203662.</narrative>
            </comment>
          </actual>
          <actual value="93.65">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 313552; Denominator: 334822.</narrative>
            </comment>
          </actual>
          <actual value="96.32">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 34865; Denominator: 36197.</narrative>
            </comment>
          </actual>
          <actual value="94.5">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 149741; Denominator: 158460.</narrative>
            </comment>
          </actual>
          <actual value="93.47">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 198676; Denominator: 212559.</narrative>
            </comment>
          </actual>
          <actual value="94.57">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 323817; Denominator: 342407.</narrative>
            </comment>
          </actual>
          <actual value="28.17">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 5099; Denominator: 18102.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="91.5">
            <comment>
              <narrative>Numerator: 150173; Denominator: 164123.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="91.5">
            <comment>
              <narrative>Numerator: 300346; Denominator: 328247.</narrative>
            </comment>
          </target>
          <actual value="93.75">
            <comment>
              <narrative>Numerator: 379995; Denominator: 405324.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="91.5">
            <comment>
              <narrative>Numerator: 150173; Denominator: 164124.</narrative>
            </comment>
          </target>
          <actual value="94.04">
            <comment>
              <narrative>Numerator: 184546; Denominator: 196239.</narrative>
            </comment>
          </actual>
          <actual value="88.91">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 337850; Denominator: 379995.</narrative>
            </comment>
          </actual>
          <actual value="11.09">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 42145; Denominator: 379995.</narrative>
            </comment>
          </actual>
          <actual value="41.53">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 157830; Denominator: 379995.</narrative>
            </comment>
          </actual>
          <actual value="58.47">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 222165; Denominator: 379995.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 0; Denominator: 194808.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 0; Denominator: 194808.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="92">
            <comment>
              <narrative>Numerator: 160196; Denominator: 174126.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 160196; Denominator: 174126.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="94">
          <comment>
            <narrative>Numerator: 346369; Denominator: 367799.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 354805; Denominator: 373479.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 709611; Denominator: 746959.</narrative>
            </comment>
          </target>
          <actual value="84.23">
            <comment>
              <narrative>Numerator: 611482; Denominator: 726005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 354806; Denominator: 373480.</narrative>
            </comment>
          </target>
          <actual value="60.62">
            <comment>
              <narrative>Numerator: 270463; Denominator: 446168.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 364846; Denominator: 384049.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 729693; Denominator: 768098.</narrative>
            </comment>
          </target>
          <actual value="117.57">
            <comment>
              <narrative>Numerator: 757653; Denominator: 644431.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 364847; Denominator: 384049.</narrative>
            </comment>
          </target>
          <actual value="117.38">
            <comment>
              <narrative>Numerator: 394051; Denominator: 335711.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 387082; Denominator: 407454.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 387082; Denominator: 407455.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="111755" />
        <baseline year="2022" iso-date="2022-12-31" value="77346">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="77346">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="966">
          <dimension name="TPT regimen" value="3HP" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="966">
          <dimension name="TPT regimen" value="3HP" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="29736">
          <dimension name="TPT regimen" value="3RH" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="29736">
          <dimension name="TPT regimen" value="3RH" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="81053">
          <dimension name="TPT regimen" value="6H" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="81053">
          <dimension name="TPT regimen" value="6H" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="35363">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="35363">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="185303" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="370606" />
          <actual value="422828" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="185303" />
          <actual value="234710" />
          <actual value="0">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="19539">
            <dimension name="TPT regimen" value="3HP" />
          </actual>
          <actual value="90507">
            <dimension name="TPT regimen" value="3RH" />
          </actual>
          <actual value="249368">
            <dimension name="TPT regimen" value="6H" />
          </actual>
          <actual value="95632">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="381095" />
          <actual value="487527" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="190547" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="190548" />
          <actual value="250424" />
          <actual value="397728">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="0">
            <dimension name="TPT regimen" value="3HP" />
          </actual>
          <actual value="0">
            <dimension name="TPT regimen" value="3RH" />
          </actual>
          <actual value="0">
            <dimension name="TPT regimen" value="6H" />
          </actual>
          <actual value="89799">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="202160" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="202160" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who completed TPT out of those who initiated TB preventive treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who completed TPT out of those who initiated TB preventive treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="84">
          <comment>
            <narrative>Numerator: 14664; Denominator: 17517.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 157507; Denominator: 185303.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 315015; Denominator: 370606.</narrative>
            </comment>
          </target>
          <actual value="92.05">
            <comment>
              <narrative>Numerator: 272873; Denominator: 296441.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 157508; Denominator: 185303.</narrative>
            </comment>
          </target>
          <actual value="91.44">
            <comment>
              <narrative>Numerator: 159561; Denominator: 174489.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 331553; Denominator: 381095.</narrative>
            </comment>
          </target>
          <actual value="83.07">
            <comment>
              <narrative>Numerator: 351260; Denominator: 422828.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="87">
            <comment>
              <narrative>Numerator: 165776; Denominator: 190547.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 165777; Denominator: 190548.</narrative>
            </comment>
          </target>
          <actual value="74.46">
            <comment>
              <narrative>Numerator: 174759; Denominator: 234710.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 181944; Denominator: 202160.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 181944; Denominator: 202160.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="91">
          <comment>
            <narrative>Numerator: 14322; Denominator: 15684.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 9576; Denominator: 9576.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 19153; Denominator: 19153.</narrative>
            </comment>
          </target>
          <actual value="88.91">
            <comment>
              <narrative>Numerator: 16871; Denominator: 18976.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 9577; Denominator: 9577.</narrative>
            </comment>
          </target>
          <actual value="91.08">
            <comment>
              <narrative>Numerator: 7463; Denominator: 8194.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 19695; Denominator: 19695.</narrative>
            </comment>
          </target>
          <actual value="92.72">
            <comment>
              <narrative>Numerator: 14703; Denominator: 15858.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 9847; Denominator: 9847.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 9848; Denominator: 9848.</narrative>
            </comment>
          </target>
          <actual value="92.65">
            <comment>
              <narrative>Numerator: 7813; Denominator: 8433.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 10447; Denominator: 10447.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 10448; Denominator: 10448.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 274247; Denominator: 282043; Percentage: 97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 115179; Denominator: 282043; Percentage: 41%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 115179; Denominator: 282043; Percentage: 41%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 159068; Denominator: 282043; Percentage: 56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 159068; Denominator: 282043; Percentage: 56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 258563; Denominator: 282043; Percentage: 92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 258563; Denominator: 282043; Percentage: 92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 15684; Denominator: 282043; Percentage: 6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 15684; Denominator: 282043; Percentage: 6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 7796; Denominator: 282043; Percentage: 3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 7796; Denominator: 282043; Percentage: 3%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 394077; Denominator: 401900; Percentage: 98.05%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 191118; Denominator: 194635; Percentage: 98.19%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 163585.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 230492.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 375101.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 18976.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 7832.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 444918; Denominator: 458534; Percentage: 97.03%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 234242; Denominator: 241433; Percentage: 97.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 190896.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 254022.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 429060.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 15858.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>